Gayle A. Crowell - Jun 5, 2025 Form 4 Insider Report for PLIANT THERAPEUTICS, INC. (PLRX)

Role: Director
Signature: /s/ Jennifer Woo, attorney-in-fact
Stock symbol: PLRX
Transactions as of: Jun 5, 2025
Transactions value $: $0
Form type: 4
Date filed: 6/9/2025, 08:42 PM
Previous filing: May 9, 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
CROWELL GAYLE A	Director	C/O PLIANT THERAPEUTICS, INC., 331 OYSTER POINT BOULEVARD, SOUTH SAN FRANCISCO	/s/ Jennifer Woo, attorney-in-fact	2025-06-09	0001250893

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PLRX	Common Stock (Right to Buy)	Award	$0	+30K		$0.00	30K	Jun 5, 2025	Common Stock	30K	$1.61	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	25% of the shares subject to such option vest and become exercisable on October 1, 2025, January 1, 2026, and April 1, 2026, respectively, and the remaining 25% of the shares subject to such option vest and become exercisable on the earlier of (i) the one-year anniversary of the June 5, 2025 grant date or (ii) the next annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer as a Director through each such date or, if earlier, such annual meeting.

Content

25% of the shares subject to such option vest and become exercisable on October 1, 2025, January 1, 2026, and April 1, 2026, respectively, and the remaining 25% of the shares subject to such option vest and become exercisable on the earlier of (i) the one-year anniversary of the June 5, 2025 grant date or (ii) the next annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer as a Director through each such date or, if earlier, such annual meeting.